BIOFILCHEM logo

Biofil CHEM & Pharma LTD

BIOFILCHEM·NSE·
32.05 -0.54 (-1.66%)
Market Cap52.95 Cr
PE Ratio94.26
Volume8,734
Day High - Low33.68 - 32.03
52W High-Low46.34 - 25.60
DocStoX Score
3.1/10
Poor
Fair Value
Sign in to see
ROE
2.98%
Weak
P/E
94.26x
Expensive
Debt / Equity
0.03
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

Day32.03
33.68
52W25.60
46.34
DocStoX take

Held back by valuation (0.0).

DocStoX score

Low confidence
3.1
/10
Poor
Quality
Weak
ROE 3.0%
Valuation
Expensive
P/E 94.3×
Growth
Steady
Revenue -4.5% 5Y CAGR
Risk
Moderate
D/E 0.03
Momentum
Weak
31% of 52-week range

At a glance

Market Cap
₹53 Cr
52W High / Low
₹46 / ₹26
Dividend Yield
0.00%
Promoter Holding
46.79%
EPS (TTM)
₹0.34
Book Value
₹11.40

Key highlights

  • Low leverage — D/E 0.03
  • Profitable in all of the last 5 years
  • Profit compounding 18% a year
  • Revenue shrinking 5% a year
  • Valuation is weak (0.0/10)
3 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

BIOFIL CHEM & PHARMA LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.